|
| Clinical observation on Shenkang injection in treating diabetic renopathy in early period |
| Hits 2028 Download times 1822 Received:April 14, 2013 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2013.09.05 |
| Key Words
Shenkang injection;diabetic kidney disease;clinical observation |
| Author Name | Affiliation | | MA Ji-wei | Tianjin University of TCM, Tianjin 300193, China
The First Affiliated Hospital of Henan University of TCM, Zhengzhou 450000, China | | WANG Hong-tian | The First Affiliated Hospital of Henan University of TCM, Zhengzhou 450000, China | | LIU Pei-na | The First Affiliated Hospital of Henan University of TCM, Zhengzhou 450000, China | | ZHANG Zhu | The First Affiliated Hospital of Henan University of TCM, Zhengzhou 450000, China |
|
| Abstract
|
| [Objective] To investigate the therapeutic effect of Shenkang injection on diabetic kidney disease in early period. [Methods] The patients were randomly divided into treatment group (36 cases) and control group (40 cases). Both groups were given quality diet with low protein. Blood pressure and plasma glucose were controlled. In addition, the patients in treatment group were given with shenkang injection, 100 mL/d for four weeks. Fasting blood glucose(FBG), 2-hour postprandial glucose (PBG), triglyceride (TG), total cholesterol (TC), blood fibrinogen (Fg), α-microglobulin (α-MG), twenty-four-hour urine protein quantitation (24 h UP), NAG and UAER were examined. [Results] Compared with those in control group, the amount of FBG, PBG, TG, TC, Fg, α-MG, NAG, UAER and 24-hour urine protein were markedly decreased in treatment group(P<0.05). [Conclusion] Shenkang injection can delay the development of diabetic renopathy. |
|
|
|
|
|
|
|
